Varex Q2 revenue $213M (+3% YoY); China tariff pause cuts Q3 outlook to $180-200M

Varex Imaging Corp

2025-Q2 EPS reported $0.16 vs consensus $0.04 ▲ beat (+348.2%)

GAAP EPS $0.17, Non-GAAP EPS $0.26 vs $0.16 prior year.
Medical segment revenue $154M (+3% YoY); Industrial $59M (+3% YoY).
Cash flow from operations $17M; cash equivalents $226M excluding $125M restricted.
Plans to repay outstanding Convertible Notes due June 2025 upon maturity.
Q3 guidance: revenue $180-200M with China ~$10M; Non-GAAP EPS -$0.05 to $0.10.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.